Pharmaceutical Executive provides news, multimedia, conferences, and publications related to the pharmaceutical industry. The platform includes resources like e-books and webcasts, supporting stakeholders in the market.

Pharmaceutical Executive

Media Production

MJH Life Sciences®

Pharmaceutical Executive | 25,906 followers on LinkedIn. Master the Science of Success | Pharmaceutical Executive provides its audience of pharmaceutical and biopharmaceutical executives with the analysis of business, strategy, and government regulations. We go beyond the news and provide in-depth analysis to help executives navigate through the maze of policy and business challenges that face this industry. We do it through the review of the issues, interviews, and roundtable discussions with thought leaders and business leaders.

Sustainability strategy and communication for the biopharma sector

Sandor Schoichet

Founder and CEO, Sea Change Healthcare Consulting

Al Reicheg

Retired Pharmaceutical Executive

Bob Graham

General Manager

Francisco José Burgos

The wait is almost over—the 2024 Pharmaceutical Executive® APEX Awards is happening this week in NYC! Join us for an evening celebrating excellence and breakthroughs in healthcare marketing. Buy your tickets before they're gone: https://ow.ly/X36Z50TZNFG #PEAPEXAwards #HealthcareExcellence #HealthcareMarketing

The sector's XBI is up 15% year-to-date; rate cuts, election outcome, and M&A are viewed as tailwinds 🖋️ Barbara Ryan

Miranda Schmalfuhs

📹 Theodore Sweetser , VP, Ad Partnerships and Strategy, PurpleLab , identifies #advertising / #marketing trends he expects in Q1 of 2025.

📍 Financial Times ’ Global Pharma and Biotech Summit 2024 Donald Trump’s victory in the 2024 US presidential election is sure to have an impact on the #pharmaceuticalindustry . During a panel at the Financial Times’ 2024 Global Pharma and Biotech Summit, the following speakers met to discuss the outcome of the election and the impact it may have on the industry: Lauren Fedor , US political correspondent and Washington deputy bureau chief at The Financial Times , Panos Kanavos , associate professor of international health policy at The London School of Economics and Political Science (LSE) , and Sebastian Guth , CEO of Bayer | Pharmaceuticals

📍 Financial Times ’ Global Pharma and Biotech Summit 2024 A panel consisting of Mads Jessen , managing director, Moelis & Company ; Marjan Noor , partner, life sciences sector lead, A&O Shearman ; and Virginia Acha , associate VP, global lead, global evidence and regulatory policy, MSD ; discussed topics such as which pharmaceutical companies are most exposed to the looming patent cliff, how companies have become more adept at protecting key drugs, the most lucrative opportunities for generic and biosimilar manufacturers, and what companies are doing to replenish pipelines.

Delivering value-based care is expected to become even more prevalent, driven by factors such as patient comfort with digital tools and advancements in contractual arrangements🖋️ Beth Houck , CEO of SonarMD

📍 Financial Times ’ Global Pharma and Biotech Summit 2024 Innovation drives the pharma industry forward. Padraic Ward , head of pharma international at Roche , spoke about the issues Europe is facing with promoting pharma innovation at the Financial Times’ 2024 Global Pharma and Biotech Summit. During the conversation, which was hosted by the Financial Times’ global pharmaceutical correspondent Ian Johnston , Ward explained how he’s the seen the innovation-friendly environment change in recent years.

PHAR

COM:PHARMEXEC

Pharmaceutical Executive